OPTN (Optinose) Return on Sales by Gross Profit

OPTN (OptiNose Inc) - company brandmark

OptiNose, Inc. (OPTN) bases its production of nasal delivery systems in the US, specializing in migraine therapy. The company is currently reducing its dependence on the XHANCE spray by penetrating the sinusitis treatment market. Analyzing the effective gross margin, it is noted that the parameter value equals 90.20. The firm's high scientific and technical potential is directed toward developing Exhalation Delivery technology to improve the bioavailability of drug formulations.

OPTN - Optinose Gross Profitability over the range 07/04/2022 - 05/31/2025

Financial and market metric breakdowns for OptiNose Inc (OPTN)

- share price and expert price forecast:
Summary company analysis:OptiNose (OPTN)
Mass-produced product of OptiNose

Gross margin measures the share of profit after deducting direct production costs, reflecting the efficiency of cost-of-goods-sold management. Investors utilize the gross margin chart to assess operational resilience and the business's ability to scale profitability without a proportional increase in expenses. For OptiNose, Inc. (OPTN), this metric depends directly on automation: the implementation of robotic component assembly reduces manual labor costs, thereby increasing final margins.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|AMPH: Gross Profit Rate|Gross Profitability pacira.com (PCRX)|Gross Margin ARS Pharma (SPRY)|Theravance Biopharma - Return on Gross Profit|Gross Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Return on Gross Profit|Gross Profit Margin Tectonic Therapeutic|TNXP: Gross Margin|SXT China (SXTC) - Gross Margin|Gross Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Return on Sales by Gross Profit|Gross Profitability Invizyne (EXOZ)|ORMP - Gross Profit Margin|Gross Margin ENTX (Entera Bio)|Gross Sales Margin MindWalk Therapeutics|ABVC: Return on Gross Profit|CPIX - Gross Margin|QNTM (Quantum BioPharma) - Return on Gross Profit|Gross Profitability Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Gross Margin|Gross Margin ranitherapeutics.com|Gross Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Gross Return on Sales|lexariabioscience.com - Return on Gross Profit|Gross Margin Pulmatrix Inc PULM|Pheton Holdings - Gross Margin|Gross Profitability Margin APM|Lyra Therapeutics, Inc. (LYRA) - Gross Profitability|Gross Profit Margin Impact BioMedical, Inc. (IBO)|Gross Profitability TNF Pharma|YCBD: Gross Profit Rate|Gross Margin PRFX|CYTO - Gross Profit Margin|Gross Profitability Lipella LIPO|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin